Pharma manufacturing continues to come under pressure in India as the country passes the half-way mark in a 21-day, country-wide lock-down enforced as part of measures to contain the spread of COVID-19.
While the pharma industry and Indian government are working in close co-ordination to address the challenges, top companies have provided...
Welcome to Scrip
Create an account to read this article
Already a subscriber?